Clinic for Endocrine Surgery, University Clinical Center of Serbia, Koste Todorovica 8, 11000, Belgrade, Serbia.
Faculty of Medicine, Belgrade University, Doktora Subotica 8, 11000, Belgrade, Serbia.
World J Surg. 2022 Oct;46(10):2416-2422. doi: 10.1007/s00268-022-06634-6. Epub 2022 Jul 7.
Post-thyroidectomy bleeding is rare, but potentially life-threatening complication. Early recognition with immediate intervention is crucial for the management of this complication. Therefore, it is very important to identify possible risk factors of postoperative hemorrhage as well as timing of postoperative hematoma occurrence.
Retrospective review of 6938 patients undergoing thyroidectomy in a tertiary center in a ten year period (2009-2019) revealed 72 patients with postoperative hemorrhage requiring reoperation. Each patient who developed postoperative hematoma was matched with four control patients that did not develop postoperative hematoma after thyroidectomy. The patients and controls were matched by the date of operation and surgeon performing thyroidectomy.
The incidence of postoperative bleeding was 1.04%. On univariate analysis older age, male sex, higher BMI, higher ASA score, preoperative use of anticoagulant therapy, thyroidectomy for retrosternal goiter, larger thyroid specimens, larger dominant nodules, longer operative time, higher postoperative blood pressure and the use of postoperative subcutaneous heparin were identified as risk factors for postoperative bleeding. Sixty-nine patients (95.8%) bled within first 24 h after surgery.
The rate of postoperative bleeding in our study is consistent with recent literature. Male sex, the use of preoperative anticoagulant therapy, thyroidectomy for retrosternal goiter and the use of postoperative subcutaneous heparin remained statistically significant on multivariate analysis (p < 0.001). When identified, these risk factors may be an obstacle to the outpatient thyroidectomy in our settings.
甲状腺切除术后出血是一种罕见但潜在危及生命的并发症。早期识别并立即干预对于该并发症的管理至关重要。因此,识别术后出血的可能危险因素以及术后血肿发生的时间非常重要。
对一家三级中心在十年期间(2009-2019 年)进行的 6938 例甲状腺切除术患者进行回顾性分析,发现 72 例需要再次手术的术后出血患者。每位发生术后血肿的患者均与 4 名未在甲状腺切除术后发生术后血肿的对照患者相匹配。通过手术日期和进行甲状腺切除术的外科医生对患者和对照患者进行匹配。
术后出血的发生率为 1.04%。单因素分析显示,年龄较大、男性、较高的 BMI、较高的 ASA 评分、术前抗凝治疗、胸骨后甲状腺肿的甲状腺切除术、较大的甲状腺标本、较大的优势结节、较长的手术时间、较高的术后血压以及术后皮下肝素的使用与术后出血的风险增加相关。69 例患者(95.8%)在术后 24 小时内出血。
我们的研究中术后出血的发生率与最近的文献一致。男性、术前抗凝治疗的使用、胸骨后甲状腺肿的甲状腺切除术和术后皮下肝素的使用在多变量分析中仍然具有统计学意义(p<0.001)。当这些危险因素被识别时,它们可能会成为我们环境中门诊甲状腺切除术的障碍。